Author:
Brigandi Richard A.,Johnson Brendan,Oei Coreen,Westerman Mark,Olbina Gordana,de Zoysa Janak,Roger Simon D.,Sahay Manisha,Cross Nicholas,McMahon Lawrence,Guptha Veerabhadra,Smolyarchuk Elena A.,Singh Narinder,Russ Steven F.,Kumar Sanjay,Borsukov Alexey V.,Marasaev Vyacheslav V.,Prasad Gullipalli,Timokhovskaya Galina Y.,Kolmakova Elena V.,Dobronravov Vladimir A.,Zakharova Elena V.,Abraham Georgi,Packham David,Zateyshchikov Dmitry A.,Arutyunov Gregory P.,Volgina Galina V.,Lipatov Kirill S.,Perlin Dmitry V.,Cooper Bruce,Kumar Saha Tarun,Zagrebelnaya Olga A.,Mehta Kalpana S.,Koziolova Natalya A.,Fassett Rob,Alexeeva Narina P.,Lysenko Lidia V.
Reference27 articles.
1. National Kidney Foundation. KDOQI guidelines, executive summaries of 2000 updates. www.kidney.org/news/newsroom/newsreleases/0173. Accessed September 12, 2014.
2. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency;McGonigle;Kidney Int,1984
3. Anemia of end-stage renal disease (ESRD);Eschbach;Kidney Int,1985
4. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease;Zaritsky;Clin J Am Soc Nephrol,2009
5. Novel erythropoiesis-stimulating agents: a new era in anemia management;Macdougall;Clin J Am Soc Nephrol,2008
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献